Pharma companies developing vaccines with efficacy against Omicron variants will gain competitive advantage in China, says GlobalData
The WHO has urged China to increase adoption of mRNA vaccines, given their high efficacy against variant strains.
The WHO has urged China to increase adoption of mRNA vaccines, given their high efficacy against variant strains.
Biocon Foundation has pioneered a mHealth-technology-based (mobile health) oral cancer screening program in India
SEZABY is a benzyl alcohol-free and propylene glycol-free formulation of phenobarbital sodium powder for injection
Cell sorting technology supports researchers advancing new therapies
OmiCrisp has been developed with support from Centre for Cellular And Molecular Platforms C-CAMP-InDx Program
Granules now have a total of 53 ANDA approvals from USFDA
Asthma patients are more likely to have an asthma attack during winter
He was previously associated with renowned companies such as Granules India Ltd, Dr. Reddy’s Laboratories ltd & Aptar Group
USFDA issued issued Form 483 with nine observations, which will be addressed within stipulated time.
The company is pleased to report positive performances from all divisions this quarter. Growth in our research divisions, Discovery Services and the Dedicated Centres was solid
Subscribe To Our Newsletter & Stay Updated